Expanding access to investigational therapies for HIV infection and AIDS : March 12-13, 1990, conference summary /

Saved in:
Bibliographic Details
Author / Creator:Nichols, Eve K.
Imprint:Washington, D.C. : National Academy Press, 1991.
Description:1 online resource (viii, 73 pages)
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11200525
Hidden Bibliographic Details
Other authors / contributors:Roundtable for the Development of Drugs and Vaccines against AIDS (Institute of Medicine)
ISBN:058515547X
9780585155470
1280203560
9781280203565
9780309583367
0309583365
0309044901
9780309044905
Digital file characteristics:data file
Notes:Includes bibliographical references.
Restrictions unspecified
Electronic reproduction. [S.l.] : HathiTrust Digital Library, 2010.
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212
English.
digitized 2010 HathiTrust Digital Library committed to preserve
Print version record.
Other form:Print version: Nichols, Eve K. Expanding access to investigational therapies for HIV infection and AIDS. Washington, D.C. : National Academy Press, 1991 0309044901
Description
Summary:The call for a parallel track for AIDS drug development--a proposal that would allow the early distribution of AIDS drugs to large numbers of patients in parallel with the conventional clinical trials that assess the drugs' safety and efficacy--has sparked controversy within the scientific community. Questions have arisen about the risks to patients of such a plan, about its potential effect on the successful completion of standard controlled trials, and about whether the parallel track will generate useful data.<br>Larger questions have also been raised about whether the parallel track heralds fundamental changes in the philosophy underlying drug regulation in the United States, about the costs and financing of investigational therapies and associated medical costs, and about the role of expanded access mechanisms for drugs in reaching those whose health care is generally inadequate. This volume summarizes a conference hosted by the Institute of Medicine that illuminated these issues.
Physical Description:1 online resource (viii, 73 pages)
Format:Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
Bibliography:Includes bibliographical references.
ISBN:058515547X
9780585155470
1280203560
9781280203565
9780309583367
0309583365
0309044901
9780309044905